| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.69B | 20.57B | 17.96B | 16.50B | 13.36B | 14.04B |
| Gross Profit | 17.69B | 20.23B | 17.96B | 16.50B | 13.36B | 14.04B |
| EBITDA | 8.52B | 10.06B | 8.27B | 9.62B | 6.88B | 6.61B |
| Net Income | 5.76B | 6.38B | 5.25B | 6.52B | 4.52B | 4.07B |
Balance Sheet | ||||||
| Total Assets | 48.38B | 57.60B | 49.94B | 46.11B | 39.38B | 37.14B |
| Cash, Cash Equivalents and Short-Term Investments | 17.88B | 19.53B | 21.39B | 22.07B | 22.03B | 19.20B |
| Total Debt | 10.56B | 10.03B | 9.00B | 9.00B | 9.34B | 9.00B |
| Total Liabilities | 15.56B | 18.39B | 16.43B | 14.69B | 13.34B | 12.82B |
| Stockholders Equity | 32.82B | 39.20B | 33.51B | 31.44B | 26.05B | 24.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.85B | 4.39B | 4.37B | 2.80B | 2.65B |
| Operating Cash Flow | 0.00 | 6.04B | 5.06B | 5.99B | 3.10B | 2.66B |
| Investing Cash Flow | 0.00 | -4.02B | -2.12B | -3.13B | 2.00B | -1.18B |
| Financing Cash Flow | 0.00 | -4.02B | -3.39B | -3.29B | -2.41B | -2.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥67.17B | 11.62 | 17.21% | 4.27% | 13.39% | 22.06% | |
72 Outperform | ¥2.03T | 5.92 | 20.02% | 2.63% | 31.37% | 148.24% | |
70 Outperform | ¥39.44B | 6.17 | 6.18% | 4.42% | 30.88% | 193.36% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥120.31B | 30.49 | 5.11% | 5.07% | -26.93% | -29.39% | |
67 Neutral | ¥174.85B | 10.15 | 7.40% | 5.60% | 15.68% | 49.07% | |
44 Neutral | ¥20.52B | -17.28 | ― | 1.85% | -17.48% | -207.17% |